Insider filing · IAM
Evan Lockwood Rachlin
Director
profile →
Iambic Therapeutics, Inc.
IAM · Healthcare · 1 filing in 24 months
ticker →
Evan Lockwood Rachlin bought $11.5M of Iambic Therapeutics (IAM)
Executed Oct 16, disclosed Oct 19, 3 days later.
Value, as filed
$11.5M
718,750 sh × $16.00
Executed
Oct 16
the trade date, as filed
Disclosed
Oct 19
3 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
not yet measured
Not yet measured: the 21-session window has not closed, or the prices around it are not on record.
The filer
EREvan Lockwood Rachlin (Director) filed 1 Form 4 report in the trailing twelve months (1 purchase, 0 sales), most often in Iambic Therapeutics, Inc. (IAM). The largest single filing was $11.5M of IAM (718,750 sh × $16.00, as filed), executed Oct 16. The median gap between execution and disclosure was 3 days.
The name
IAMHealthcare · Iambic Therapeutics, Inc. operates as a biotechnology company that develops therapeutics from its AI discovery platform that optimizes targ…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→